Jonathan Peacock

2016

In 2016, Jonathan Peacock earned a total compensation of $470.3K as former Chief Executive Officer at Bellerophon Therapeutics, a 60% decrease compared to previous year.

Compensation breakdown

Option Awards$206,920
Salary$253,846
Other$9,538
Total$470,304

Peacock received $253.8K in salary, accounting for 54% of the total pay in 2016.

Peacock also received $206.9K in option awards and $9.5K in other compensation.

Rankings

In 2016, Jonathan Peacock's compensation ranked 11,390th out of 14,075 executives tracked by ExecPay. In other words, Peacock earned more than 19.1% of executives.

ClassificationRankingPercentile
All
11,390
out of 14,075
19th
Division
Manufacturing
4,437
out of 5,489
19th
Major group
Chemicals And Allied Products
1,590
out of 1,895
16th
Industry group
Drugs
1,285
out of 1,538
16th
Industry
Pharmaceutical Preparations
1,001
out of 1,176
15th
Source: SEC filing on March 20, 2017.

Peacock's colleagues

We found three more compensation records of executives who worked with Jonathan Peacock at Bellerophon Therapeutics in 2016.

2016

Fabian Tenenbaum

Bellerophon Therapeutics

Chief Executive Officer

2016

Peter Fernandes

Bellerophon Therapeutics

Chief Regulatory and Safety Officer

2016

Deborah Quinn

Bellerophon Therapeutics

Chief Medical Officer

You may also like